About Biopharma’s Ridiculously Bad Day: Brainstorm Health

Biopharma didn’t exactly have the most wonderful Thursday going into the weekend. Three companies – Sarepta Therapeutics, Nektar Therapeutics, and Amarin -all had to deal with some unfortunate news in the span of hours. Sarepta stock is down 6.5% after hours. Nektar? Down more than 27%. And Amarin – a company that’s enjoyed major spikes […]

A $43 Billion Biotech Now Has a Female CEO: Brainstorm Health

Good afternoon, readers. A pretty rare thing happened this morning—a woman became the chief executive of a major biopharmaceutical company. Reshma Kewalramani, a physician and, until now, the chief medical officer at Vertex Pharmaceuticals, will become its next CEO. She’s taking over the role from Jeff Leiden, who has led the rare disease-focused firm—a company […]